uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
44.00
-0.09 (-0.20%)
At close: Sep 18, 2026, 4:00 PM EDT
44.20
+0.20 (0.45%)
After-hours: Sep 18, 2026, 7:30 PM EDT
uniQure Market Cap
uniQure has a market cap or net worth of $3.05 billion as of September 18, 2026. Its market cap has increased by 292.86% in one year.
Market Cap
3.05B
Enterprise Value
2.79B
1-Year Change
292.86%
Ranking
Category
Stock Price
$44.00
ChartMarket Cap Chart
Since March 15, 2017, uniQure's market cap has increased from $161.10M to $3.05B, an increase of 1,794.55%. That is a compound annual growth rate of 36.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 3.05B | 104.76% |
| Dec 31, 2025 | 1.49B | 73.16% |
| Dec 31, 2024 | 860.80M | 165.93% |
| Dec 29, 2023 | 323.70M | -69.50% |
| Dec 30, 2022 | 1.06B | 10.73% |
| Dec 31, 2021 | 958.50M | -40.38% |
| Dec 31, 2020 | 1.61B | -48.57% |
| Dec 31, 2019 | 3.13B | 190.93% |
| Dec 31, 2018 | 1.07B | 78.06% |
| Dec 29, 2017 | 603.40M | 274.55% |
| Mar 15, 2017 | 161.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 3.42B |
| Legend Biotech | 3.41B |
| Dyne Therapeutics | 3.37B |
| Arcutis Biotherapeutics | 3.33B |
| Arcus Biosciences | 3.25B |
| Denali Therapeutics | 3.22B |
| MBX Biosciences | 3.08B |
| Celldex Therapeutics | 3.06B |